ONPH OTC
Oncology Pharma Inc.
1W: -25.0%
1M: -55.8%
3M: -40.2%
YTD: +650.0%
1Y: +5900.0%
3Y: -91.7%
5Y: -99.9%
$0.03
-0.01 (-32.28%)
Weekly Expected Move ±55.2%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$2M
+510.7% ▲
5Y CAGR: +3.9%
Total Liabilities
$875K
+69.2% ▲
5Y CAGR: -0.1%
Shareholders Equity
$1M
+833.5% ▲
5Y CAGR: +7.4%
Cash & Investments
$4K
-55.7% ▼
5Y CAGR: -68.8%
Total Debt
$662K
+177.7% ▲
Net Debt
$658K
+186.8% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2004 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $8K | $7K | $2K | $9K | $4K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $8K | $7K | $2K | $9K | $4K |
| Net Receivables | $19K | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $21K | $0 | $0 | $0 | $0 |
| Total Current Assets | $48K | $7K | $2K | $9K | $4K |
| Property, Plant & Equip. | $0 | $2K | $779 | $0 | $0 |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $182K | $228K | $339K | $2M |
| Other Non-Current Assets | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Assets | $0 | $184K | $229K | $339K | $2M |
| Total Assets | $48K | $191K | $231K | $348K | $2M |
| — Liabilities — | |||||
| Accounts Payable | $195K | $0 | $0 | $0 | $0 |
| Short-Term Debt | $25K | $238K | $129K | $238K | $662K |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $165K | $165K | $279K | $213K |
| Total Current Liabilities | $220K | $403K | $295K | $518K | $875K |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $220K | $403K | $295K | $518K | $875K |
| — Equity — | |||||
| Common Stock | $13K | $125K | $150K | $182K | $189K |
| Retained Earnings | -$26M | -$70M | -$70M | -$167M | -$272M |
| Accumulated OCI | $0 | $100K | -$150K | -$182K | -$189K |
| Total Stockholders Equity | -$172K | -$213K | -$64K | -$170K | $1M |
| Total Liabilities & Equity | $48K | $191K | $231K | $348K | $2M |
| — Key Metrics — | |||||
| Total Debt | $25K | $238K | $129K | $238K | $662K |
| Net Debt | $17K | $231K | $128K | $229K | $658K |
| Total Investments | $0 | $182K | $228K | $339K | $2M |